Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Learn how online tools can help you efficiently find investment opportunities. Simplify your investment search with technology.
22,540 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Gen Z and Gen Alpha are turning fan culture into a driver of personal finance and economic power, pressuring brands t...
Uber is acquiring SpotHero to add parking reservations inside the Uber app, a move that signals a broader push to tur...
Coinbase stock has fallen sharply this year, yet a cadre of analysts believes a turnaround is possible as the company...
Retail traders are shifting capital from crypto to stocks, marking a sharp pivot after Bitcoin's peak. January 2026 s...
Retirees may be over-diversifying their portfolios, risking income stability as markets move. New analysis suggests a...
A major issuer boosted its quarterly dividend by 16%, even as shares retreat. This article breaks down what that sign...
Harvard Management Company disclosed a strategic reallocation of its crypto portfolio, trimming Bitcoin ETF exposure ...
Ethereum activity on Binance surged to a six-month peak as volatility returns. Analysts note heavy turnover and fast-...
Asana appoints veteran tech executive Dan Rogers as CEO and highlights that breaking into Silicon Valley has always b...
Analysts warn that Nvidia's GTC event may not deliver the dramatic stock move some investors were banking on. The con...
The SEC and CFTC announced a formal partnership to harmonize crypto regulation and pursue new digital asset products....